The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / RA Patients with ILD & Liver Disease Present Treatment Challenges

RA Patients with ILD & Liver Disease Present Treatment Challenges

November 12, 2020 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR CONVERGENCE 2020—Patients with concurrent rheumatological arthritis (RA) and liver disease or interstitial lung disease or treatment-refractory rheumatoid arthritis pose treatment challenges, according to the panelists of the ACR Convergence 2020’s How I Treat Difficult RA: Panel Session. Each panelist discussed a difficult case and raised questions on how to best treat it.

You Might Also Like
  • Experts Discuss Unique Challenges Posed by Difficult-to-Treat RA
  • Treatment Tips for Pulmonary Arterial Hypertension & ILD
  • Catch Your Breath: Insights into ILD in RA Patients
Also By This Author
  • State of the Art Session Reviews Lupus Causes, Potential Treatments

Joan M. Bathon, MD, chief, Division of Rheumatology, New York Presbyterian Hospital/Columbia University, New York, presented the case of a 65-year-old man found to have RA and interstitial lung disease (ILD) as well as probable heart failure. She raised treatment questions such as whether methotrexate or leflunomide caused or worsened his ILD and whether there was a disease-modifying anti-rheumatic drug that could treat both his ILD and RA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Josef Smolen, MD, chairman, Division of Rheumatology, Medical University of Vienna, Vienna, discussed several types of patients with difficult-to-treat RA, including those with ILD, chronic infections such as hepatitis B, cardiovascular disease, and those who do not adhere to treatments. With many efficacious drugs available, rheumatologists should switch to other agents when the ones currently used clearly do not work in difficult-to-treat RA patients, Dr. Smolen advises.

Stanley Cohen, MD, co-medical director, Metroplex Clinical Research Center, Dallas, focused on concurrent liver disease with RA, presenting the case of a 64-year-old female patient with symmetrical polyarthritis who was found to have hepatitis B reactivation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Watch this page for our full report on this session.

Filed Under: ACR Convergence, Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR Convergence 2020, ACR Convergence 2020 – RA

You Might Also Like:
  • Experts Discuss Unique Challenges Posed by Difficult-to-Treat RA
  • Treatment Tips for Pulmonary Arterial Hypertension & ILD
  • Catch Your Breath: Insights into ILD in RA Patients
  • What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)